M

Microbiotica

HealthBiotechnologyB2B

Microbiotica is developing a new treatment for inflammatory bowel disease. The company has secured €42 million in funding to advance its novel therapies. This funding will support the progression of their pipeline and further research into gut microbiome-based treatments.

Total raised
Undisclosed
tracked to date
Latest round
€42 million
Oct 16, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    €42 millionOct 16, 2026
    Announcement ↗

Microbiotica in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile